Reviva Pharmaceuticals Holdings Inc — Quarterly Dividends (NASDAQ:RVPH) | MetaTrader

Open full chart

Notícias

Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia

Chardan Capital inicia cobertura da Reviva Pharmaceuticals com recomendação de compra

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com

H.C. Wainwright mantém recomendação de compra para ações da Reviva Pharmaceuticals

Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%

E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 0,16%

Ações da Reviva Pharmaceuticals despencam após FDA solicitar segundo estudo de Fase 3

Reviva Pharmaceuticals stock plunges after FDA requests second Phase 3 trial

FDA recomenda segundo ensaio de fase 3 para medicamento de esquizofrenia da Reviva

FDA recommends second phase 3 trial for Reviva’s schizophrenia drug